Severe serum sickness following pneumococcal vaccination in an AIDS patient [1]

International Journal of STD and AIDS

Volumn 17, Issue 3, 2006, Pages 210-211

  Hengge, Ulrich R ^a   Scharf, Ruediger E ^a   Kroon, Frank P ^b   Pfeffer, Klaus ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DARUNAVIR; DIDANOSINE; LOPINAVIR PLUS RITONAVIR; PNEUMOCOCCUS VACCINE; RAMIPRIL; TELMISARTAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; AIDS PATIENT; CASE REPORT; CD4 LYMPHOCYTE COUNT; DISEASE SEVERITY; DRUG FEVER; GLOMERULONEPHRITIS; HEMATURIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LETTER; LIPODYSTROPHY; LOBAR PNEUMONIA; LOW BACK PAIN; MALAISE; MALE; MYALGIA; PANCREATITIS; PRIORITY JOURNAL; PROTEINURIA; SERUM SICKNESS; SOMNOLENCE; VACCINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGED; HIV INFECTIONS; HUMANS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES; SERUM SICKNESS;

EID: 33644545677     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646206775809123     Document Type: Letter

References (5)

1. Dear K, Holden J, Andrews R, Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2003;4:CD000422
2. Masur H, Kaplan JE, Holmes KK, US Public Health Service; Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002;137:435-78
3. Wise RP, Iskander J, Pratt RD, et al. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA 2004;292:1702-10
4. Ekstrom N, Ahman H, Verho J, et al. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infect Immun 2005;73:369-77
5. Watera C, Nakiyingi J, Miiro G, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS 2004;18:1210-13